Dr. Stubbeman’s Bio
Dr. Stubbeman is a certified TMS psychiatrist who has trained with the most prominent TMS physicians in the country including Dr. Sarah H. Lisanby at Duke and Dr. Alvaro Pascual-Leone at Harvard. Dr. Stubbeman’s innovative TMS protocol has yielded notably high remission rates for major depressive disorder, and his published work can be found in the July 2018 issue of Brain Stimulation Journal.
Dr. Stubbeman graduated magna cum laude from Princeton with a degree in Mechanical and Aerospace Engineering and received his MD from Columbia University. He began his training at UCLA as an Ear, Nose and Throat Surgeon specializing in auditory pathology but his growing interest in the brain caused him to switch his focus to Psychiatry.
Upon completion of his residency in 1998, he held a two-year research fellowship at UCLA where he authored a number of scientific publications on early prediction of response to antidepressants and ECT. Dr. Stubbeman subsequently built a thriving psychiatry private practice in West Los Angeles specializing in treatment-refractory psychopharmacology. After realizing the potential of TMS to help patients that were beyond the reach of medications, he expanded the scope of his practice to include TMS treatment.
Dr. Stubbeman’s Research:
- Bilateral neuronavigated 20Hz theta burst TMS for treatment refractory depression: An open label study
William F. Stubbeman, Bijan Zarrabi, Silvia Bastea, Victoria Ragland, Raya Khairkhah (2018). Bilateral Neuronavigated TBS-20Hz TMS brought more than two-thirds of treatment refractory depressed patients to remission. TBS-20Hz may be critical for obtaining higher remission rates. Controlled trials are warranted. Brain Stimulation Journal, online. - Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study
Cook, I. A., Leuchter, A. F., Morgan, M. L., Stubbeman, W., Siegman, B., & Abrams, M. (2005). Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of psychiatric research, 39(5), 461-466. - Pretreatment neurophysiologic function and ECT response in depression
Stubbeman, W. F., Leuchter, A. F., Cook, I. A., Shurman, B. D., Morgan, M., Gunay, I., & Gonzalez, S. (2004). Pretreatment neurophysiologic function and ECT response in depression. The journal of ECT, 20(3), 142-144. - Early changes in prefrontal activity characterize clinical responders to antidepressants
Cook, I. A., Leuchter, A. F., Morgan, M., Witte, E., Stubbeman, W. F., Abrams, M., … & Uijtdehaage, S. H. (2002). Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology, 27(1), 120-131. - Corrigendum to ‘Neurophysiologic predictors of treatment response to fluoxetine in major depression’
Cook, I. A., Leuchter, A. F., Witte, E., Abrams, M., Uijtdehaage, S. H., Stubbeman, W., … & Dunkin, J. J. (2000). Corrigendum to ‘Neurophysiologic predictors of treatment response to fluoxetine in major depression’:[Psychiatry Research 85 (1999) 263–273] 1PII of original article: S0165-1781 (99) 00010-41. Psychiatry Research, 95(1), 87. - Neurophysiologic predictors of treatment response to fluoxetine in major depression
Cook, I. A., Leuchter, A. F., Witte, E., Abrams, M., Uijtdehaage, S. H., Stubbeman, W., … & Anderson-Hanley, C. (1999). Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry research, 85(3), 263-273. - Electromechanical analogs of human reflexes
Littman, M. G., Liker, M., Stubbeman, W., Russakow, J., McGEE, C., Gelfand, J., & Call, B. J. (1989). Electromechanical Analogs of Human Reflexesa. Annals of the New York Academy of Sciences, 563(1), 184-193.